Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: Implications for antipsychotic drug treatment

Journal of Pharmacology and Experimental Therapeutics

Volumn 297, Issue 2, 2001, Pages 711-717

  Tarazi, Frank I ^a   Zhang, Kehong ^b   Baldessarini, Ross J ^b  

^a MCLEAN HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; EXTRAPYRAMIDAL SYMPTOM; FOREBRAIN; HIPPOCAMPUS; LONG TERM CARE; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RAT; RECEPTOR UPREGULATION;

ANIMALS; ANTIPSYCHOTIC AGENTS; AUTORADIOGRAPHY; BENZODIAZEPINES; BRAIN CHEMISTRY; DIBENZOTHIAZEPINES; DOPAMINE ANTAGONISTS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; PIRENZEPINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RISPERIDONE;

EID: 0035038086     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. The functional anatomy of basal ganglia disorders
2. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence
3. Clozapine - A novel antipsychotic agent
4. Brain dopamine receptors: A primer on their current status, basic and clinical
5. Drugs and the treatment of psychiatric disorders
6. Pathophysiologic basis of neurologic side-effects of antipsychotic drugs
7. Emerging principles of altered neural circuitry in schizophrenia
8. New insights into the biology of schizophrenia through the action mechanism of clozapine
9. Radioreceptor binding profile of the atypical antipsychotic olanzapine
10. Selective antidopaminergic effects of S(+)-N-n-propylnoraporphines in limbic vs. extrapyramidal sites in rat brain: Comparisons with typical and atypical antipsychotic agents
11. Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex
12. 1 antagonist SCH 39166 in six cases of acute psychotic states
13. Activity of Seroquel (ICI-204,636) in animal models for atypical properties of antipsychotics, comparison with clozapine
14. 2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics
15. Risperidone and olanzapine: Clinical use and experience
16. Dopamine receptor subtypes: Differential regulation following 8 months treatment with antipsychotic drugs
17. Chronic olanzapine or sertindole treatment results in reduced oral chewing movements in rats compared to haloperidol
18. 2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine in patients with schizophrenia
19. 2 receptor expression in hippocampus and parahippocampal cortex of rat, cat, and human in relation to tyrosine hydroxylase-immunoreactive fibers
20. Quetiapine: A review of its use in schizophrenia
21. 2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia
22. Paranoid schizophrenia may be caused by dopamine hyperactivity of CA1 hippocampus
23. 2C receptors after chronic treatment with clozapine chlorpromazine three putative atypical antipsychotic drugs
24. Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain
25. 2-type dopamine receptors in postmortem human brain sections from normal and schizophrenic subjects
26. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo: A meta-analysis of randomized controlled trials
27. 3 dopamine receptor: Neurobiology and potential clinical relevance
28. 3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons
29. 2-dopamine receptors in the primate cerebral cortex
30. 4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: Effects of chronic treatment with typical and atypical antipsychotic drugs
31. 2 pKi vales
32. The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent
33. 4 dopamine receptors in postmortem striatum from patients with schizophrenia
34. 3 receptor agonist
35. Antipsychotic regulation of hippocampal dopamine messenger RNA expression
36. 4 receptors by 2-fold in rats
37. Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding
38. 4 receptors elevated in schizophrenia
39. 3) as a target for neuroleptics
40. Differential regulation of dopamine receptors following chronic typical and atypical antipsychotic drug treatment
41. 4 receptors in rat forebrain
42. 4-like dopamine receptors
43. 4-like dopamine receptors: Common targets for typical, atypical and experimental antipsychotics
44. Olanzapine, quetiapine and risperidone: Long-term effects on monoamine transporters in rat forebrain
45. Atypical antipsychotic agents: Effects on extrapyramidal function
46. 4 receptor gene with high affinity for the antipsychotic clozapine
47. Comparative pharmacology of classical and novel (second-generation) antipsychotics
48. 3 receptors: Selective protection by dopamine